Company Information

LYKA LABS LTD.

NSE : LYKALABSBSE : 500259ISIN CODE : INE933A01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE128.851.2 (+0.94 %)
PREV CLOSE ( ) 127.65
OPEN PRICE ( ) 130.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7716
TODAY'S LOW / HIGH ( )128.20 131.90
52 WK LOW / HIGH ( )89 143.5
NSE128.800.85 (+0.66 %)
PREV CLOSE( ) 127.95
OPEN PRICE ( ) 129.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 80215
TODAY'S LOW / HIGH( ) 128.05 131.95
52 WK LOW / HIGH ( )88.5 144.3
ChairmanBabulal Jain
Managing DirectorKunal N Gandhi
Company SecretaryKishore P Shah
Executive DirectorYogesh Shah
Non Executive DirectorPrashant Godha
Shashil P Mendonsa
Non Executive Independent DirectorDhara Shah
Incorporation Year : 29-12 1976

Registered Office :

Address : 4801/B & 4802/A,G I D C Industrial Estate, Ankleshwar,
Gujarat-393002 .

Phone : 02646221422 /220549

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.